These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 22052650)
1. Experience with use of Zostavax(®) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Naidus E; Damon L; Schwartz BS; Breed C; Liu C Am J Hematol; 2012 Jan; 87(1):123-5. PubMed ID: 22052650 [No Abstract] [Full Text] [Related]
2. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients. Chun JY; Kim K; Lee MK; Kang CK; Koh Y; Shin DY; Hong J; Choe PG; Kim NJ; Yoon SS; Park WB; Kim I; Oh MD BMC Infect Dis; 2021 Jan; 21(1):117. PubMed ID: 33499826 [TBL] [Abstract][Full Text] [Related]
4. Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients. Weinstock DM; Boeckh M; Sepkowitz KA Biol Blood Marrow Transplant; 2006 Oct; 12(10):1096-7. PubMed ID: 17084374 [No Abstract] [Full Text] [Related]
5. Herpes zoster in a 13-year-old healthy immunocompetent female patient. Wan KS; Su YM Med Mal Infect; 2011 Mar; 41(3):156-7. PubMed ID: 21087834 [No Abstract] [Full Text] [Related]
6. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation. Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065 [TBL] [Abstract][Full Text] [Related]
7. Zoster vaccine: current status and future prospects. Oxman MN Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454 [TBL] [Abstract][Full Text] [Related]
8. The immunogenicity and safety of zoster vaccine in Taiwanese adults. Yao CA; Chen LK; Huang KC Vaccine; 2015 Mar; 33(13):1515-7. PubMed ID: 25681662 [TBL] [Abstract][Full Text] [Related]
9. Herpes zoster-associated voiding dysfunction in hematopoietic malignancy patients. Imafuku S; Takahara M; Uenotsuchi T; Iwato K; Furue M Int J Dermatol; 2008 Jan; 47(1):36-9. PubMed ID: 18173598 [TBL] [Abstract][Full Text] [Related]
10. Effect of acyclovir and prednisolone on the serological response in herpes zoster. Bates CJ; Kudesia G; McKendrick MW J Med Virol; 1996 Nov; 50(3):244-8. PubMed ID: 8923289 [TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical characteristics of herpes zoster after lung transplantation. Manuel O; Kumar D; Singer LG; Cobos I; Humar A J Heart Lung Transplant; 2008 Jan; 27(1):11-6. PubMed ID: 18187081 [TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119 [TBL] [Abstract][Full Text] [Related]